Cantitate/Preț
Produs
Total produse
Vezi coșul
Atypical Diabetes de Boris Draznin

Atypical Diabetes

Autor Boris Draznin
en Limba Engleză Paperback
Although the vast majority of diabetes cases (type 1 and type 2) are polygenic diseases, research, funded by the American Diabetes Association, has found that some forms of diabetes, distinct from type 1 or type 2 diabetes, are caused by single gene mutations. It has been estimated that these monogenic forms of diabetes account for up to five percent of all diabetes cases.
Citește tot Restrânge

Preț: 45760 lei

Preț vechi: 49740 lei
-8% Nou

Puncte Express: 686
Preț estimativ în valută:
8762€ • 9029$ • 7353£

Carte indisponibilă temporar


Wish list
Gift list
Am citit!
Adaugă în listă
Doresc să fiu notificat când acest titlu va fi disponibil:
Trimite
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781580406666
ISBN-10: 1580406661
Pagini: 560
Greutate: 0.84 kg

Descriere

Although the vast majority of diabetes cases (type 1 and type 2) are polygenic diseases, research, funded by the American Diabetes Association, has found that some forms of diabetes, distinct from type 1 or type 2 diabetes, are caused by single gene mutations. It has been estimated that these monogenic forms of diabetes account for up to five percent of all diabetes cases. In addition to monogenic diabetes, there are other atypical causes of diabetes, including: genetic defects in insulin action; diseases of the exocrine pancreas; and endocrinopathies.

Given recent advances in our understanding of sub-types of diabetes, the time has come for a book on how to correctly diagnose and treat patients with atypical forms of this disorder. The book will be divided into three parts, each exploring distinct categories of atypical diabetes.

Part I: Monogenic Diabetes: Genetic Defects of β-cell development and function; Part II: Insulin resistance, genetic defects in insulin action, and diseases of exocrine pancreas; Part III: Endocrinopathies, Immune-mediated diabetes, Diabetes of Unknown cause, and Other genetic syndromes sometimes associated with diabetes.

Notă biografică

Boris Draznin, MD, PhD, is the Celeste and Jack Grynberg Professor of Medicine and a Director of the Adult Diabetes Program at the University of Colorado School of Medicine. Dr. Draznin is a member of the American Society of Clinical Investigation, Association of American Physicians, American Diabetes Association, American Association of Clinical Endocrinologists, and the Endocrine Society. Dr. Draznin served as Chair, Professional Section Advisory Panel of the American Diabetes Association, and President of the Western Association pf Physicians. He has published over 150 scientific articles and written or edited 27 books, including Diabetes Case Studies and Managing Diabetes and Hyperglycemia in the Hospital Setting, both published by the American Diabetes Association.

Cuprins

  • Table of Contents

  • Preface xiii

  • Introduction xv

  • PART I: Monogenic Diabetes: Genetic Defects of ß-cell Development and Function

  • Chapter 1: Maturity-Onset Diabetes of the Young (MODY) and Neonatal Diabetes -- 3
    • R. Naylor, S.A. Greeley, D. Carmody, J.L. Hwang, M. Sanyoura, L.R. Letourneau, G.I. Bell, and L. Philipson

  • Part I Case Studies Introduction -- 37


  • Case 1: KCNJ11 ¿ DEND: Neonatal Diabetes -- 41
    • L. Letourneau, M. Sanyoura, L. Dickens, S.A. Greeley, R. Naylor, G.I. Bell, and L. Philipson

  • Case 2: ABCC8 Neonatal Diabetes -- 44
    • L. Letourneau, M. Sanyoura, L. Dickens, S.A. Greeley, R. Naylor, G.I. Bell, and L. Philipson

  • Case 3: INS ¿ Insulin Gene Mutation in Neonatal Diabetes -- 47
    • L. Letourneau, M. Sanyoura, L. Dickens, S.A. Greeley, R. Naylor, GI. Bell, and L. Philipson

  • Case 4: STAT3 and Neonatal Diabetes -- 51
    • D.W. Hansen, J.C. Sanchez, and T.S. Hannon

  • Case 5: GATA6 ¿ Heart and Pancreas -- 55
    • T. Triolo and K. Simmons

  • Case 6: KCNJ11 R201C ¿ Neonatal Diabetes -- 61
    • L.M. Nally and D.M. Wilson

  • Case 7: PDX1 ¿ Pancreatic Agenesis -- 67
    • M. Sanyoura, L. Letourneau, L. Dickens, S.A. Greeley, R. Naylor, G.I. Bell, and L. Philipson

  • Case 8: Neonatal Diabetes and Congenital Hypothyroidism: GLIS3 -- 70
    • M. Sanyoura, L. Letourneau, L. Dickens, S.A. Greeley, R. Naylor, G.I. Bell, and L. Philipson

  • Case 9: EIF2AK3: Wolcott-Rallison Syndrome -- 73
    • M. Sanyoura, L. Letourneau, L. Dickens, S.A. Greeley, R. Naylor, G.I. Bell, and L. Philipson

  • Case 10: Transient Neonatal Diabetes -- 76
    • E.O. Buschur and K. Dungan

  • Case 11: GCK-MODY -- 81
    • L. Dickens, M. Sanyoura, L. Letourneau, S.A. Greeley, R. Naylor, G.I. Bell, and L. Philipson

  • Case 12: HNF1A ¿ MODY -- 84
    • L. Dickens, M. Sanyoura, L. Letourneau, S.A. Greeley, R. Naylor, G.I. Bell, and L. Philipson

  • Case 13: HNF4A ¿ MODY -- 87
    • L. Dickens, M. Sanyoura, L. Letourneau, S.A. Greeley, R. Naylor, G.I. Bell, and L. Philipson

  • Case 14: MODY as a Possible Diagnosis -- 90
    • I. Jamil and J.L. Gilden

  • Case 15: Could This Be MODY vs. Type 2? -- 95
    • B.Z. Osmani, J.L. Gilden, A. Moid, and C. Harris

  • Case 16: Misclassification of MODY 3 as Type 1 -- 100
    • L. Song, J.N. McNulty, and I. Lingvay

  • Case 17: Wolfram Syndrome WFS1 -- 105
    • J. Sarhis-Avigdor and E. Cengi

  • Case 18: Mitochondrial Diabetes -- 109
    • C. Sullivan and S. Alexanian

  • >G Mutation -- 115
    • B.P. Galm, S. Sirrs, and R.O. Yeung

  • >G 120
    • A.L. Frederilsen and H. Beck-Nielsen

  • Case 21: Maternally Inherited Diabetes and Deafness: 23-Year Follow-Up -- 125
    • I. Ahmad and I.B. Hirsch

  • Case 22: Glycogen Storage Type 1A Presenting with Diabetes Mellitus Type 2 -- 130
    • D. Sistla, M. Korytkowski, S. Mon

  • PART II: Insulin Resistance, Genetic Defects in Insulin Action, and Diseases of Exocrine Pancreas


  • Chapter 2: Insulin Resistance: Molecular Biology and Pathophysiology -- 135
    • C.L. Wang and B. Draznin

  • Chapter 3: The Lipodystrophy Syndromes: Clinical Features and Treatments -- 155
    • M. Mattingly, A. Valencia, E. Cochran, R.J. Brown, and P. Gorden

  • Chapter 4: Diabetes in Diseases of Exocrine Pancreas -- 181
    • J. Abramowitz, U. Gunasekaran, X.F. Samaropoulos, A. Tumyan, and I. Lingvay

  • Part II Case Studies Introduction -- 215


  • Case 23: Type A Insulin Resistance -- 218
    • A. Stears and R.K. Semple

  • Case 24: Donohue Syndrome (Leprechaunism) -- 225
    • C. Peters and R.K. Semple

  • Case 25: Rabson-Mendelhall Syndrome -- 232
    • R. Williams and R.K. Semple

  • Case 26: Familial Partial Lipodystrophy II (Dunninan¿s Syndrome) -- 239
    • P.K. Cabandugama, S.A. Brietzke, M.J. Gardner, and J. Sowers

  • Case 27: Familial Partial Lipodystrophy -- 243
    • K.E. Kreider and M. Feinglos

  • Case 28: Severe Insulin Resistance and Lipodystrophy -- 248
    • K. Mekala and J. Aloi

  • Case 29: Lipodystrophy Due to PPAR-¿ Gene Mutation -- 253
    • A. Hodes, R. Brown, E. Cochran, M. Zilbermint

  • Case 30: Congenital Generalized Lipodystrophy -- 259
    • H. Beck-Nielsen

  • Case 31: Pancreatogenic Diabetes Mellitus --263
    • N. Zherdeva and B. Mankovsky

  • Case 32: A Case of Pancreatogenic Diabetes due to Alcohol Abuse --267
    • B.Z. Osmani, J.L. Gilden, and A. Moid

  • Case 33: Post-Pancreatectomy Diabetes -- 273
    • E.D. Buras, R. Cianchandani, and J. Wyckoff

  • Case 34: Diabetes and Hemochromatosis -- 277
    • D. Maggi, A. Aleo, L. Briatore, C. Mazzucchelli, L. Fontana, and R. Cordera

  • Case 35: Bronze Diabetes -- 281
    • E. Meyerhoff

  • Case 36: Type 2 Diabetes in Liver Cirrhosis and Hepatocellular Carcinoma -- 285
    • S. Ravi, A. Moid, J.L. Gilden, and D. Karam

  • Case 37: Poor Glycemic Control in Insulin-Treated Diabetes Due to Anti-Insulin Antibodies -- 290
    • D. S. Church and R.K. Semple

  • Case 38: Cystic Fibrosis-Related Diabetes -- 296
    • R. Iyengar, R.Y. Gianchandani, and J. Wyckoff

  • Case 39: Pembrolizumab and Diabetic Ketoacidosis -- 300
    • F. Cottini and K. Dungan

  • Case 40: Glycemic Control in Patient with Multiple Chronic Complications -- 305
    • A. Iqbal, J.L. Gilden, B.G. Theckadeth, S. Rapaka, and D. Dai

  • Case 41: Diabetes and Exposure to Agent Orange -- 309
    • B.Z. Osmani, J.L. Gilden, C. Harris

  • Case 42: Pasireotride-Induced Hyperglycemia -- 313
    • K. Brau and A. Drincic

  • Case 43: Hemoglobin A1C vs. Fructosamine -- 318
    • A. Iqbal, J.L. Gilden, B.G. Theckadeth, S. Rapaka, and D. Dai

  • Part III: Endocrinopathies, Immune-Mediated Diabetes, Diabetes of Unknown Cause, and Other Genetic Syndromes Sometimes Associated with Diabetes


  • Chapter 5: Diabetes Secondary to Endocrinopathies -- 325
    • J. M. Silverstein, K. Sterl, J. L Cartier, P. Cruz-Bravo, C. A. Davis, S. Sadiq, and J.B McGill

  • Chapter 6. Immune-Mediated Diabetes -- 357
    • M.F. Salam, J.W. Hughes, and J.B. McGill

  • Chapter 7. Diabetes of Unknown Cause -- 383
    • Y. Azhar, C.A. Baker, and N. Rasouli

  • Chapter 8. Genetic Syndromes Associated with Diabetes -- 395
    • A.C.H Wood, D. Abreu, A.L. Clark, M.A. Malbas, J.E. Sprague, and J.B. McGill

  • Part III Case Studies Introduction -- 423


  • Case 44: Acromegaly and Diabetic Ketoacidosis -- 426
    • P. Akkireddy and A. Drincic

  • Case 45: Cushing¿s Syndrome and Diabetes -- 431
    • K. Peicher and L. Meneghini
    Case 46: Pheochromocytoma and Diabetes -- 436K. Modzelewski and D. Steenkamp
  • Case 47: Hypertension plus Hyperglycemia may be Equal to Pheochromocytoma -- 442
    • L.L. Yanes-Cardozo, V. Garla, and L. Lien

  • Case 48: Pheochromocytoma and Pre-Existing Diabetes -- 447
    • P. Akkireddy and A. Drincic

  • Case 49: Glucagonoma as a Cause of Diabetes -- 452
    • H. Beck-Nielsen

  • Case 50: Type 1 or Type 2 Diabetes vs. LADA -- 455
    • I. Jamil and J.L. Gilden

  • Case 51: LADA Masquerading as Type 2 Diabetes -- 459
    • N. Misaghian-Xanthos

  • Case 52: LADA During the Obesity Epidemic -- 462
    • L. Viswanathan and C. Vaz

  • Case 53: LADA in Older Adults -- 467
    • L. Viswanathan and C. Vaz

  • Case 54: Stiff Person Syndrome -- 472
    • H.N. Kim and N. Mathioudakis

  • Case 55: Polyglandular Failure and Diabetes -- 476
    • B.Z. Osmani, J.L. Gilden, A. Moid, and D. Dai

  • Case 56: Type B Insulin Resistance Syndrome -- 481
    • S. Ahern, H. Nguyen, Y. Lyou, S. Singh, and P. Wang

  • Case 57: Remission of Type B Insulin Resistance -- 486
    • J. Giordano, M.S. Kalia-Reynolds, C. Houston, R. Tanenberg, R.J. Brown, RK. Semple, and F. Cook

  • Case 58: Ketosis-Prone Type 2 Diabetes -- 492
    • J. Patel and C. Knight

  • Case 59: Ketosis-Prone Diabetes: Case Report -- 497
    • A. Milanesi and J. Weinreb

  • Case 60: Ketosis-Prone Diabetes Mellitus -- 501
    • S. Ahmed and R. Tenenberg

  • Case 61: Prader-Willi Syndrome -- 506
    • J.L. Gilden and B.Z. Osmani

  • Case 62: Bardet-Biedl Syndrome -- 512
    • J.J. Iyengar, R.Y. Gianchandani, and J. Wyckoff

  • Case 63: Williams-Beuren Syndrome and Diabetes -- 517
    • M. Gaule and A. Drincic

  • Case 64: Spinal and Bulbar Muscle Atrophy and Diabetes -- 522
    • S. Ravi, J.L. Gilden, A. Moid, B. Theckedath, and J. Afranie-Sakyi

  • Index -- 527

    •